As I march slowly toward the twilight of my life, ever more I wake up with aches and pains and can hear the sounds of popping bubble wrap or Rice Krispies drowning in milk every time I make any major movements. Everyone deals with the realization of their own mortality in different ways. Some decide to finally climb Mount Everest or go skydiving. For me, I decided to look into the research behind cellular aging, and how we can make the most of our later years with the power of knowledge and biomedical science. This does remind me of that one episode of Star Trek where Jake and Nog have to get stuff for a mad scientist's cellular regeneration and entertainment chamber, which is supposed to restore the cells to a younger state and keep them from being literally bored to death. If you consider some of the treatments and technology being implemented or proposed these days, it almost seems like Star Trek has inspired yet another advancement beyond just cell phones and Alexa.

The term apoptosis was first used in 1972 to describe a morphologically distinct form of cell death. Since those early experiments and observations, apoptosis has become one of the focal points for biological research, with myriad laboratories and research groups continuing to work to further elucidate the components and pathways that drive this programmed cell death. As a fundamental biological pathway, apoptosis has benefits and adverse effects for the host organism. For example, many therapeutic strategies involve the activation of apoptosis to kill cancer cells, while other treatments seek to prevent apoptosis to preserve precious cells in key tissues. 

AIFM1, also known as Apoptosis Inducing Factor (AIF), is a widely expressed flavoprotein that plays an important role in caspase-independent apoptosis. AIF normally exists in the mitochondrial intermembrane space.